Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Beijing Kreate Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (2). The latest was on 2026-08-14.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-08-14 | 510(k) | K261646 | Redermax® Antibacterial Wound Matrix |
| 2026-02-02 | 510(k) | K251582 | Redermax Antibacterial Wound Matrix |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Beijing Kreate Medical.